April 8, 2021: PrEP “contemplation” and uptake among adolescents; adolescent perception of HIV risk; HIV diagnosis rates among transgender people; PrEP and HIV incidence in Scotland.
April 1, 2021: The ethics of teaching U=U; the role of primary care in HIV service acceptance; STI testing rates in transgender women; the potential in anal self-sampling.
Researchers recommend PrEP programs be linked to a gender-affirming care clinic, to build trust and retain patients in care.
The incidence of anal cancer is rapidly growing in the United States, and may overtake cervical cancer within the next 10 years.
Beyond the big-picture improvements, a closer look at the data reveals stark racial and geographic disparities in HIV incidence and prevalence.
The findings add to evidence that injectable PrEP could ultimately have greater real-world efficacy than daily oral PrEP in many populations, thanks to better adherence.
Jan. 28, 2021: COVID-19 information mistrust among Black PLWH; opportunities to intervene prior to deadly drug overdoses; we're unprepared for end-of-life needs for aging PLWH; hospitalization disparities despite universal health care.
“ARCA started because there was a heartbreaking need for new drugs to treat HIV,” says Melanie Thompson, M.D. “The landscape for HIV research has indeed changed, largely as a result of our successes.”
When organizations commit to cultural humility at the structural level through organizational accountability, HIV care can be far more responsive, community-focused, and of higher quality.
Dec. 28, 2020: The power of clinic-pharmacy collaborations; overcoming COVID-19-induced barriers to HIV care; urine testing as a PrEP adherence tool; using incarceration history in PrEP Rx assessments.